Stay updated on Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The only observed change is the revision label updated from v3.3.3 to v3.3.4, with no visible updates to study details, eligibility criteria, or other page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:22:07.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-12-23T20:25:48.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The Publications note was updated to say that PubMed publications are automatically filled from PubMed and may not be about the study. The revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T20:58:26.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removed the government funding/status notice from the page footer, and the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:22:52.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant changes observed; the study details (objectives, endpoints, eligibility, enrollment, and results) remain unchanged, with only minor formatting/layout adjustments visible in the screenshots — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:05:39.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Summary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:38:30.000Z thumbnail image

Stay in the know with updates to Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.